Drug General Information
Drug ID
D0S4CE
Former ID
DNC014788
Drug Name
VL-0494
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528737]
Structure
Download
2D MOL

3D MOL

Formula
C38H25N3O3
Canonical SMILES
C1=CC=C(C=C1)C2=CC=C(C=C2)C=CC3=C4C=CC(=O)C(=C4N5C6=CC=<br />CC=C6NC5=C3)CN7C(=O)C8=CC=CC=C8C7=O
InChI
1S/C38H25N3O3/c42-34-21-20-28-27(19-16-24-14-17-26(18-15-24)25-8-2-1-3-9-25)22-35-39-32-12-6-7-13-33(32)41(35)36(28)31(34)23-40-37(43)29-10-4-5-11-30(29)38(40)44/h1-22,39H,23H2/b19-16+
InChIKey
DVNWIOVXJYWOGK-KNTRCKAVSA-N
PubChem Compound ID
Target and Pathway
Target(s) Cholecystokinin receptor type A Target Info Inhibitor [528737]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Insulin secretion
Pancreatic secretion
Reactome Peptide ligand-binding receptors
G alpha (q) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 528737Bioorg Med Chem Lett. 2007 May 15;17(10):2749-55. Epub 2007 Mar 3.Synthesis and evaluation of novel benzimidazole derivative [Bz-Im] and its radio/biological studies.
Ref 528737Bioorg Med Chem Lett. 2007 May 15;17(10):2749-55. Epub 2007 Mar 3.Synthesis and evaluation of novel benzimidazole derivative [Bz-Im] and its radio/biological studies.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.